A survey of intensity-modulated radiation therapy use in the United States

Cancer

Volumn 98, Issue 1, 2003, Pages 204-211

  Mell, Loren K ^a   Roeske, John C ^a   Mundt, Arno J ^a,b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Dose escalation; Intensity modulated radiation therapy; Radiation oncologists; Survey

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL PRACTICE; HEAD AND NECK CANCER; HEALTH SURVEY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; PHYSICIAN; PRIORITY JOURNAL; RADIATION DOSE; TECHNOLOGY; UROGENITAL TRACT TUMOR;

DATA COLLECTION; HUMANS; NEOPLASMS; QUESTIONNAIRES; RADIATION ONCOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; UNITED STATES;

EID: 0038339687     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11489     Document Type: Article

References (45)

1. Leibel SA, Fuks Z, Zelefsky MJ, et al. Intensity-modulated radiation therapy. Cancer J. 2002;8:164-176.
2. Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol. 1999;9:78-98.
3. Eisbruch A, Marsh LH, Martel MK, et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys. 1998;41:559-568.
4. Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000; 48:329-337.
5. van Dieren EB, Nowak PJ, Wijers OB, et al. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck. Int J Radiat Oncol Biol Phys. 2000;47:1299-1309.
6. Cheng JC, Chao KS, Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer (Radiat Oncol Invest). 2001;96:126-131.
7. Nutting CM, Convery DJ, Cosgrove VP, et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol. 2001;60:163-172.
8. Woo SY, Grant WH III, Bellezza D, et al. A comparison of intensity modulated conformal therapy with a conventional external beam stereotactic radiosurgery system for the treatment of single and multiple intracranial lesions. Int J Radiat Oncol Biol Phys. 1996;35:593-597.
9. Cardinale RM, Benedict SH, Wu Q, et al. A comparison of three stereotactic radiotherapy techniques; ARCS vs. noncoplanar fixed fields vs. intensity modulation. Int J Radiat Oncol Biol Phys. 1998;42:431-436.
10. Leavitt DD, Watson G, Tobler M, et al. Intensity-modulated radiosurgery/radiotherapy using a micromultileaf collimator. Med Dosimetry. 2001;26:143-150.
11. Hong L, Hunt M, Chui C, et al. Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys. 1999;44:1155-1164.
12. Li JG, Williams SS, Goffinet DR, et al. Breast-conserving radiation therapy using combined electron and intensity-modulated radiotherapy technique. Radiother Oncol. 2000;56:65-71.
13. Lo YC, Yasuda G, Fitzgerald TJ, et al. Intensity modulation for breast treatment using static multileaf collimators. Int J Radiat Oncol Biol Phys. 2000;46:187-194.
14. van Asselen B, Raaijmakers CP, Hofman P, et al. An im-proved breast irradiation technique using three-dimensional geometrical information and intensity modulation. Radiother Oncol. 2001;58:341-347.
15. Derycke S, De Gersem WR, Van Duyse BB, et al. Conformal radiotherapy of stage III non-small cell lung cancer: a class solution involving non-coplanar intensity-modulated beams. Int J Radiat Oncol Biol Phys. 1998;41:771-777.
16. van Sornsen de Koste J, Voet P, Dirkx M, et al. An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer. Lung Cancer. 2001;32:145-153.
17. Landry JC, Yang GY, Ting JY, et al. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Med Dosimetry. 2002;27:121-129.
18. Nutting CM, Bedford JL, Cosgrove VP, et al. A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol. 2001;61:157-163.
19. Chmura SJ, Johnson S, Heimann R. Normal tissue toxicity using intensity modulated radiation therapy (IMRT) in pancreatic cancer and cholangiocarcinoma [abstract]. Proc Am Soc Clin Oncol. 2001;20(Suppl 1):274a.
20. Nutting CM, Convery DJ, Cosgrove VP, et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48:649-656.
21. De Meerleer GO, Vakaet LA, De Gersem WR, et al. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys. 2000;47:639-648.
22. Martinez AA, Yan D, Lockman D, et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys. 2001;50:1226-1234.
23. Roeske JC, Lujan A, Rotmensch J, et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2000;48:1613-1621.
24. Portelance L, Chao KS, Grigsby PW, et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51:261-266.
25. Hong L, Alektiar K, Chui C, et al. IMRT of large fields: whole-abdomen irradiation. Int J Radiat Oncol Biol Phys. 2002;54:278.
26. Kavanagh BD, Schefter TE, Wu Q, et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol. 2002;12:260-271.
27. Chen Q, Izadifar N, King S, et al. Comparison of IMRT with 3-D CRT for gynecologic malignancies [abstract]. Int J Radiat Oncol Biol Phys. 2001;51:332.
28. Kuppersmith RB, Teh BS, Donovan DT, et al. The use of intensity modulated radiotherapy for the treatment of extensive and recurrent juvenile angiofibroma. Int J Pediatr Otorhinolaryngol. 2000;52:261-268.
29. Paulino AC, Skwarchuk M. Intensity-modulated radiation therapy in the treatment of children. Med Dosimetry. 2002;27:115-120.
30. Millar BM, Bragg CM, Conway J, et al. Investigation of the use of intensity modulated radiotherapy (IMRT) in comparison with conformal radiotherapy in the management of soft tissue sarcoma [abstract]. Int J Radiat Oncol Biol Phys. 2001;51(Suppl 1):412.
31. Eisbruch A, Kim HM, Terrell JE, et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695-704.
32. Chao KS, Low DA, Perez CA, et al. Intensity-modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Int J Cancer (Radiat Oncol Invest). 2000;90:92-103.
33. Mundt AJ, Lujan AE, Rotmensch J, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;52:1330-1337.
34. Brixey C, Roeske JC, Lujan AE, et al. Impact of intensity modulated whole pelvic radiation therapy on acute hematologic toxicity in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;54:1388-1396.
35. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001;166:1839.
36. Huang E, Teh BS, Strother DR, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys. 2002;52:599-605.
37. Teh BS, Mai WY, Uhl BM, et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys. 2001;49:705-712.
38. Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys. 2000;48:1559-1568.
39. Landry J, Esiashvili N, Ting J, et al. Intensity modulated radiation therapy employing the volume at risk approach to minimize small bowel and renal toxicity when treating patients with locally advanced pancreatic carcinomas [abstract]. Int J Radiat Oncol Biol Phys. 2001;51(Suppl 1):270.
40. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1336-1343.
41. Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001;61:275-280.
42. Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002;53:1111-1116.
43. Carmichael M, Murdock J, Rappleye C. "Your next..." Newsweek. June 24, 2002;139:64-66.
44. Brown E. "Cancer in the crosshairs." Forbes. October 28, 2002;170:361-364.
45. Glatstein E. The return of the snake oil salesmen. Int J Radiat Oncol Biol Phys. 2003;55:561-562.